Literature DB >> 30655314

Circulating Tumor DNA in Advanced Anal Cancer: A Blood Biomarker Goes Viral.

Van K Morris1.   

Abstract

Circulating tumor DNA (ctDNA) as a blood-based biomarker for mutation detection is an exciting, highly sensitive approach in the clinical management of oncology patients. In human papillomavirus-associated malignancies like anal cancer, a viral-specific probe can be utilized for ctDNA detection in the majority of patients to predict clinical outcomes.See related article by Bernard-Tessier et al., p. 2109. ©2019 American Association for Cancer Research.

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 30655314      PMCID： PMC6445727          DOI： 10.1158/1078-0432.CCR-18-3982

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN： 1078-0432            Impact factor:   12.531


  5 in total

1.  Clinical Validity of HPV Circulating Tumor DNA in Advanced Anal Carcinoma: An Ancillary Study to the Epitopes-HPV02 Trial.

Authors:  Alice Bernard-Tessier; Emmanuelle Jeannot; David Guenat; Alice Debernardi; Marc Michel; Charlotte Proudhon; Anne Vincent-Salomon; Ivan Bièche; Jean-Yves Pierga; Bruno Buecher; Aurélia Meurisse; Éric François; Romain Cohen; Marine Jary; Véronique Vendrely; Emmanuelle Samalin; Farid El Hajbi; Nabil Baba-Hamed; Christophe Borg; François-Clément Bidard; Stefano Kim
Journal:  Clin Cancer Res       Date:  2018-11-30       Impact factor: 12.531

2.  Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.

Authors:  Van Morris; Xiayu Rao; Curtis Pickering; Wai Chin Foo; Asif Rashid; Karina Eterovic; Taebeom Kim; Ken Chen; Jing Wang; Kenna Shaw; Cathy Eng
Journal:  Mol Cancer Res       Date:  2017-08-07       Impact factor: 5.852

3.  Structure and transcription of human papillomavirus sequences in cervical carcinoma cells.

Authors:  E Schwarz; U K Freese; L Gissmann; W Mayer; B Roggenbuck; A Stremlau; H zur Hausen
Journal:  Nature       Date:  1985 Mar 7-13       Impact factor: 49.962

4.  Analysis of Plasma Epstein-Barr Virus DNA to Screen for Nasopharyngeal Cancer.

Authors:  K C Allen Chan; John K S Woo; Ann King; Benny C Y Zee; W K Jacky Lam; Stephen L Chan; Sam W I Chu; Constance Mak; Irene O L Tse; Samantha Y M Leung; Gloria Chan; Edwin P Hui; Brigette B Y Ma; Rossa W K Chiu; Sing-Fai Leung; Andrew C van Hasselt; Anthony T C Chan; Y M Dennis Lo
Journal:  N Engl J Med       Date:  2017-08-10       Impact factor: 91.245

5.  Circulating human papillomavirus DNA detected using droplet digital PCR in the serum of patients diagnosed with early stage human papillomavirus-associated invasive carcinoma.

Authors:  Emmanuelle Jeannot; Véronique Becette; Maura Campitelli; Marie-Ange Calméjane; Emmanuelle Lappartient; Evelyne Ruff; Stéphanie Saada; Allyson Holmes; Dominique Bellet; Xavier Sastre-Garau
Journal:  J Pathol Clin Res       Date:  2016-06-28
  5 in total
  2 in total

Review 1.  Metastatic or Locally Recurrent Anal Squamous Cell Carcinoma (SCAC): Current Clinical Trial Landscape and Novel Approaches.

Authors:  Jane E Rogers; Michael Leung; Benny Johnson
Journal:  Cancer Manag Res       Date:  2022-06-21       Impact factor: 3.602

2.  Atezolizumab plus modified docetaxel-cisplatin-5-fluorouracil (mDCF) regimen versus mDCF in patients with metastatic or unresectable locally advanced recurrent anal squamous cell carcinoma: a randomized, non-comparative phase II SCARCE GERCOR trial.

Authors:  Stefano Kim; Bruno Buecher; Thierry André; Marine Jary; François-Clément Bidard; François Ghiringhelli; Éric François; Julien Taieb; Denis Smith; Christelle de la Fouchardière; Jérôme Desramé; Emmanuelle Samalin; Aurélie Parzy; Nabil Baba-Hamed; Olivier Bouché; David Tougeron; Laëtitia Dahan; Farid El Hajbi; Marion Jacquin; Magali Rebucci-Peixoto; Laurie Spehner; Véronique Vendrely; Dewi Vernerey; Christophe Borg
Journal:  BMC Cancer       Date:  2020-04-25       Impact factor: 4.430
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.